BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 22021615)

  • 21. The herpes simplex virus type 1 latency-associated transcript inhibits phenotypic and functional maturation of dendritic cells.
    Chentoufi AA; Dervillez X; Dasgupta G; Nguyen C; Kabbara KW; Jiang X; Nesburn AB; Wechsler SL; Benmohamed L
    Viral Immunol; 2012 Jun; 25(3):204-15. PubMed ID: 22512280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The herpes simplex virus 1 latency-associated transcript promotes functional exhaustion of virus-specific CD8+ T cells in latently infected trigeminal ganglia: a novel immune evasion mechanism.
    Chentoufi AA; Kritzer E; Tran MV; Dasgupta G; Lim CH; Yu DC; Afifi RE; Jiang X; Carpenter D; Osorio N; Hsiang C; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2011 Sep; 85(17):9127-38. PubMed ID: 21715478
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells.
    Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L
    J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining the herpes simplex virus-specific CD8+ T cell repertoire in C57BL/6 mice.
    St Leger AJ; Peters B; Sidney J; Sette A; Hendricks RL
    J Immunol; 2011 Apr; 186(7):3927-33. PubMed ID: 21357536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Qa-1b and CD94-NKG2a interaction regulate cytolytic activity of herpes simplex virus-specific memory CD8+ T cells in the latently infected trigeminal ganglia.
    Suvas S; Azkur AK; Rouse BT
    J Immunol; 2006 Feb; 176(3):1703-11. PubMed ID: 16424200
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization with different viral antigens alters the pattern of T cell exhaustion and latency in herpes simplex virus type 1-infected mice.
    Allen SJ; Mott KR; Zandian M; Ghiasi H
    J Virol; 2010 Dec; 84(23):12315-24. PubMed ID: 20861248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Galectin-9 increases Tim-3+ dendritic cells and CD8+ T cells and enhances antitumor immunity via galectin-9-Tim-3 interactions.
    Nagahara K; Arikawa T; Oomizu S; Kontani K; Nobumoto A; Tateno H; Watanabe K; Niki T; Katoh S; Miyake M; Nagahata S; Hirabayashi J; Kuchroo VK; Yamauchi A; Hirashima M
    J Immunol; 2008 Dec; 181(11):7660-9. PubMed ID: 19017954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.
    Matundan H; Mott KR; Ghiasi H
    J Virol; 2014 Jul; 88(14):8016-27. PubMed ID: 24807710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice.
    Ghiasi H; Perng G; Nesburn AB; Wechsler SL
    Microb Pathog; 1999 Dec; 27(6):387-94. PubMed ID: 10588911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medroxyprogesterone acetate inhibits CD8+ T cell viral-specific effector function and induces herpes simplex virus type 1 reactivation.
    Cherpes TL; Busch JL; Sheridan BS; Harvey SA; Hendricks RL
    J Immunol; 2008 Jul; 181(2):969-75. PubMed ID: 18606648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD8+ T cells patrol HSV-1-infected trigeminal ganglia and prevent viral reactivation.
    St Leger AJ; Hendricks RL
    J Neurovirol; 2011 Dec; 17(6):528-34. PubMed ID: 22161682
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Level of herpes simplex virus type 1 latency correlates with severity of corneal scarring and exhaustion of CD8+ T cells in trigeminal ganglia of latently infected mice.
    Mott KR; Bresee CJ; Allen SJ; BenMohamed L; Wechsler SL; Ghiasi H
    J Virol; 2009 Mar; 83(5):2246-54. PubMed ID: 19091870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impairment in reactivation of a latency associated transcript (LAT)-deficient HSV-2 is not solely dependent on the latent viral load or the number of CD8(+) T cells infiltrating the ganglia.
    Hoshino Y; Pesnicak L; Straus SE; Cohen JI
    Virology; 2009 Apr; 387(1):193-9. PubMed ID: 19269661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates of reactivation of latent herpes simplex virus from mouse trigeminal ganglia ex vivo correlate directly with viral load and inversely with number of infiltrating CD8+ T cells.
    Hoshino Y; Pesnicak L; Cohen JI; Straus SE
    J Virol; 2007 Aug; 81(15):8157-64. PubMed ID: 17522198
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lymphocytes delay kinetics of HSV-1 reactivation from in vitro explants of latent infected trigeminal ganglia.
    Noisakran S; Carr DJ
    J Neuroimmunol; 1999 Mar; 95(1-2):126-35. PubMed ID: 10229122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses.
    Sharma S; Sundararajan A; Suryawanshi A; Kumar N; Veiga-Parga T; Kuchroo VK; Thomas PG; Sangster MY; Rouse BT
    Proc Natl Acad Sci U S A; 2011 Nov; 108(47):19001-6. PubMed ID: 22052881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD8 T cell control of HSV reactivation from latency is abrogated by viral inhibition of MHC class I.
    Orr MT; Mathis MA; Lagunoff M; Sacks JA; Wilson CB
    Cell Host Microbe; 2007 Sep; 2(3):172-80. PubMed ID: 18005732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galectin-9 ameliorates herpes simplex virus-induced inflammation through apoptosis.
    Shim JA; Park S; Lee ES; Niki T; Hirashima M; Sohn S
    Immunobiology; 2012 Jun; 217(6):657-66. PubMed ID: 22204815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phenotypic and Functional Signatures of Herpes Simplex Virus-Specific Effector Memory CD73
    Srivastava R; Coulon PG; Roy S; Chilukuri S; Garg S; BenMohamed L
    J Immunol; 2018 Oct; 201(8):2315-2330. PubMed ID: 30201808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.